FDA Approved: SIROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for sirolimus by Mylan Pharmaceuticals, authorizing changes to the approved product through a supplemental approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection Prophylaxis
• Kidney Transplant Rejection Prophylaxis
• Liver Transplant Rejection Prophylaxis
• Solid Organ Transplant Rejection Prophylaxis

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

SUPPL AP for SIROLIMUS (SIROLIMUS)